Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pirfenidone in Combination With Standard of Care Treatment in Patients With Advanced Liver Fibrosis. Multicenter, Open Trial Focused on Safety, Fibrosis Efficacy Evaluation, and Pharmacokinetic Data.

NCT04099407 is registered in ClinicalTrials.gov with Grupo Mexicano para el Estudios de las Enfermedades Hepaticas as lead sponsor.

NCT NCT04099407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04099407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pirfenidone in Combination With Standard of Care Treatment in Patients With Advanced Liver Fibrosis. Multicenter, Open Trial Focused on Safety, Fibrosis Efficacy Evaluation, and Pharmacokinetic Data.
Lead sponsor
Grupo Mexicano para el Estudios de las Enfermedades Hepaticas
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2019
Completion date
December 31, 2020
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease, liver fibrosis